Document Detail


Hurthle cell tumor.
MedLine Citation:
PMID:  8912085     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hurthle cell tumor is rare type of thyroid tumor. There are few recent reports about the proper management of patients with Hurthle cell tumors. We reviewed our patients from 1988 to 1994 with pathological proof of Hurthle cell tumor. There were 26 patients in total: four cases were Hurthle cell carcinoma and the other twenty-two cases were Hurthle cell adenoma. Only one patient with Hurthle cell carcinoma is male and all the others were female. All of them except one with metastatic bone lesion presented with painless neck mass. The mean size of the tumor in carcinoma patients is 3.7 cm and in adenoma patient 2.3 cm. Five patients had multiple adenoma. The mean age of carcinoma patients is 49.5 years and the adenoma patients 45.1 years. No patient had a history of exposure to low dose radiation. The only carcinoma patient with bone metastases has positive radioactive iodine uptake. Lobectomy is advised for adenoma patients and total thyroidectomy for carcinoma patients. There were no operative complications in these patients. No local recurrence or metastases occurred in those patients with Hurthle cell adenoma. One patient with adenoma died of poorly differentiated thyroid carcinoma. Our conclusion is that most Hurthle cell tumors have a gender preponderance toward female. Carcinoma patients seem to be older than adenoma patients and tumor size is larger, but no discriminative point can be found. Pathological diagnosis with capsular or vascular invasion is accurate for differentiating benign from malignant tumors. No benign adenoma tumor had recurrence or metastases during follow up. Lobectomy is adequate for adenoma patients and total thyroidectomy for carcinoma patients. All of these patients need long term follow-up.
Authors:
H Y Chen; L B Benjamin; M F Chen
Related Documents :
7332305 - Non-surgical treatment of thyroid carcinoma.
1694985 - Chemotherapy and multimodality treatment in thyroid carcinoma.
16967785 - A randomized clinical trial comparing 50mci and 100mci of iodine-131 for ablation of di...
16552205 - Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in ...
8745585 - Factors affecting removal and prognosis of thymic tumors.
16703785 - Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete mohs...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International surgery     Volume:  81     ISSN:  0020-8868     ISO Abbreviation:  Int Surg     Publication Date:    1996 Apr-Jun
Date Detail:
Created Date:  1997-02-19     Completed Date:  1997-02-19     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0043524     Medline TA:  Int Surg     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  168-70     Citation Subset:  IM    
Affiliation:
Department of General Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / surgery*
Adenoma, Oxyphilic / surgery*
Adult
Aged
Female
Humans
Male
Middle Aged
Retrospective Studies
Thyroid Neoplasms / surgery*
Thyroidectomy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Controversies in the surgical management of differentiated thyroid carcinoma.
Next Document:  Cardiac output in asymptomatic primary hyperparathyroidism: a stigma of early cardiovascular dysfunc...